107 related articles for article (PubMed ID: 27127813)
21. Using the NCDB to explore trends in cancer.
Hopewood P
Bull Am Coll Surg; 2017 Jul; 102(7):78-80. PubMed ID: 28885797
[No Abstract] [Full Text] [Related]
22. A novel zebrafish human tumor xenograft model validated for anti-cancer drug screening.
Jung DW; Oh ES; Park SH; Chang YT; Kim CH; Choi SY; Williams DR
Mol Biosyst; 2012 Jul; 8(7):1930-9. PubMed ID: 22569777
[TBL] [Abstract][Full Text] [Related]
23. Building avatar armies with fish and flies.
Neff EP
Lab Anim (NY); 2020 Apr; 49(4):101-104. PubMed ID: 32210417
[No Abstract] [Full Text] [Related]
24. "Thyroid cancer" cell line misidentification: a time for proactive change.
Ringel MD
J Clin Endocrinol Metab; 2008 Nov; 93(11):4226-7. PubMed ID: 18987282
[No Abstract] [Full Text] [Related]
25. Peginterferon Beta-1a Shows Antitumor Activity as a Single Agent and Enhances Efficacy of Standard of Care Cancer Therapeutics in Human Melanoma, Breast, Renal, and Colon Xenograft Models.
Boccia A; Virata C; Lindner D; English N; Pathan N; Brickelmaier M; Hu X; Gardner JL; Peng L; Wang X; Zhang X; Yang L; Perron K; Yco G; Kelly R; Gamez J; Scripps T; Bennett D; Joseph IB; Baker DP
J Interferon Cytokine Res; 2017 Jan; 37(1):20-31. PubMed ID: 27835061
[TBL] [Abstract][Full Text] [Related]
26. [Abnormal expression of insulin-like growth factor-I receptor and inhibitory effect of its transcription intervention on nude mice xenograft tumor].
Yao M; Yan XD; Cai Y; Gu JJ; Yang XL; Pan LH; Wang L; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2016 Nov; 24(11):846-851. PubMed ID: 27978931
[No Abstract] [Full Text] [Related]
27. Antitumor effect of kigamicin D on mouse tumor models.
Masuda T; Ohba S; Kawada M; Osono M; Ikeda D; Esumi H; Kunimoto S
J Antibiot (Tokyo); 2006 Apr; 59(4):209-14. PubMed ID: 16830887
[TBL] [Abstract][Full Text] [Related]
28. Patient-Derived Xenografts of Breast Cancer.
Varešlija D; Cocchiglia S; Byrne C; Young L
Methods Mol Biol; 2017; 1501():327-336. PubMed ID: 27796962
[TBL] [Abstract][Full Text] [Related]
29. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
[TBL] [Abstract][Full Text] [Related]
30. Physician Data Query (PDQ(R)) update.
J Natl Cancer Inst; 2012 May; 104(9):655-6. PubMed ID: 22517987
[No Abstract] [Full Text] [Related]
31. Lidocaine Induces Apoptosis and Suppresses Tumor Growth in Human Hepatocellular Carcinoma Cells In Vitro and in a Xenograft Model In Vivo.
Xing W; Chen DT; Pan JH; Chen YH; Yan Y; Li Q; Xue RF; Yuan YF; Zeng WA
Anesthesiology; 2017 May; 126(5):868-881. PubMed ID: 28121635
[TBL] [Abstract][Full Text] [Related]
32. End of cancer-genome project prompts rethink.
Ledford H
Nature; 2015 Jan; 517(7533):128-9. PubMed ID: 25567260
[No Abstract] [Full Text] [Related]
33. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
[TBL] [Abstract][Full Text] [Related]
34. What's Next for Patient-Derived Xenograft Modeling?
Gritters J
J Natl Cancer Inst; 2017 Jul; 109(7):. PubMed ID: 29982758
[No Abstract] [Full Text] [Related]
35. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
[TBL] [Abstract][Full Text] [Related]
36. Molecular heterogeneity of non-small cell lung carcinoma patient-derived xenografts closely reflect their primary tumors.
Wang D; Pham NA; Tong J; Sakashita S; Allo G; Kim L; Yanagawa N; Raghavan V; Wei Y; To C; Trinh QM; Starmans MH; Chan-Seng-Yue MA; Chadwick D; Li L; Zhu CQ; Liu N; Li M; Lee S; Ignatchenko V; Strumpf D; Taylor P; Moghal N; Liu G; Boutros PC; Kislinger T; Pintilie M; Jurisica I; Shepherd FA; McPherson JD; Muthuswamy L; Moran MF; Tsao MS
Int J Cancer; 2017 Feb; 140(3):662-673. PubMed ID: 27750381
[TBL] [Abstract][Full Text] [Related]
37. 3D cancer cells library.
Nat Biotechnol; 2016 Nov; 34(11):1086. PubMed ID: 27824833
[No Abstract] [Full Text] [Related]
38. Inhibition of DNA damage repair by the CDK4/6 inhibitor palbociclib delays irradiated intracranial atypical teratoid rhabdoid tumor and glioblastoma xenograft regrowth.
Hashizume R; Zhang A; Mueller S; Prados MD; Lulla RR; Goldman S; Saratsis AM; Mazar AP; Stegh AH; Cheng SY; Horbinski C; Haas-Kogan DA; Sarkaria JN; Waldman T; James CD
Neuro Oncol; 2016 Nov; 18(11):1519-1528. PubMed ID: 27370397
[TBL] [Abstract][Full Text] [Related]
39. Xenograft models for preclinical drug testing: implications for adrenocortical cancer.
Luconi M; Mannelli M
Mol Cell Endocrinol; 2012 Mar; 351(1):71-7. PubMed ID: 22056412
[TBL] [Abstract][Full Text] [Related]
40. Challenges in Stratifying the Molecular Variability of Patient-Derived Colon Tumor Xenografts.
Cybulska M; Olesinski T; Goryca K; Paczkowska K; Statkiewicz M; Kopczynski M; Grochowska A; Unrug-Bielawska K; Tyl-Bielicka A; Gajewska M; Mroz A; Dabrowska M; Karczmarski J; Paziewska A; Zając L; Bednarczyk M; Mikula M; Ostrowski J
Biomed Res Int; 2018; 2018():2954208. PubMed ID: 30662905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
